• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/112 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulfur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/112

Total number of patents in this class: 67

10-year publication summary

7
5
0
6
5
6
5
4
5
3
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Recurium IP Holdings, LLC
125
7
The Cooper Health System
45
4
National University Corporation Ehime University
127
4
National University Corporation Kochi University
107
4
SRI International
992
4
Iowa State University Research Foundation, Inc.
825
3
Neuropore Therapies, Inc.
31
2
The United States of America,as represented by the Secretary, Department of Health and Human Service
124
2
Novartis AG
10263
1
Glaxosmithkline Intellectual Property (no.2) Limited
302
1
Shin-Etsu Chemical Co., Ltd.
6083
1
Abbvie Inc.
1836
1
AbbVie Deutschland GmbH & Co. KG
258
1
The United States of America as represented by the Secretary of the Army
1256
1
Boe Technology Group Co., Ltd.
44004
1
Changzhou Tronly Advanced Electronic Materials Co., Ltd.
88
1
Changzhou Tronly New Electronic Materials Co.,Ltd.
85
1
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
379
1
Ideaya Biosciences, Inc.
160
1
Institute for Research in Biomedicine
98
1
Other owners 25